Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eva E Shrader"'
Autor:
Ziding Feng, Eva E Shrader, Lynn M. Matrisian, Joshua A. Roth, Suresh T. Chari, Naomi R. M. Schwartz
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:451-459
Background: There are no established methods for pancreatic cancer (PAC) screening, but the NCI and the Pancreatic Cancer Action Network (PanCAN) are investigating risk-based screening strategies in patients with new-onset diabetes (NOD), a group wit
Autor:
Ying-Qi Zhao, Suresh T. Chari, Anirban Maitra, Lynn M. Matrisian, Eva E. Shrader, Bechien U. Wu, Avinash Kambadakone, Barbara Kenner, Jo Ann S. Rinaudo, Sudhir Srivastava, Ying Huang, Ziding Feng
Publikováno v:
Cancer Research. 82:A028-A028
The Early Detection Initiative (EDI) is an innovative study designed to build a platform that will evaluate novel approaches to early detection of resectable pancreatic ductal adenocarcinoma (PDAC) in patients over age 50 with new onset hyperglycemia
Autor:
Suresh T. Chari, Anirban Maitra, Lynn M. Matrisian, Eva E. Shrader, Bechien U. Wu, Avinash Kambadakone, Ying-Qi Zhao, Barbara Kenner, Jo Ann S. Rinaudo, Sudhir Srivastava, Ying Huang, Ziding Feng
Publikováno v:
Contemp Clin Trials
Pancreatic ductal adenocarcinoma (PDAC) is the only leading cause of cancer death without an early detection strategy. In retrospective studies, 0.5–1% of subjects >50 years of age who newly develop biochemically-defined diabetes have been diagnose
Autor:
Lynn M. Matrisian, Suresh T. Chari, Joshua A. Roth, Ziding Feng, Naomi R. M. Schwartz, Eva E Shrader
Publikováno v:
Journal of Clinical Oncology. 38:7017-7017
7017 Background: There are no established methods for pancreatic cancer (PC) screening, but the National Cancer Institute and the Pancreatic Cancer Action Network (PanCAN) are investigating risk-based screening strategies in new-onset diabetes (NOD)
Autor:
Xie F; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States., Chang J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States., Luong T; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States., Wu B; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States., Lustigova E; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States., Shrader E; Pancreatic Cancer Action Network, Manhattan Beach, CA, United States., Chen W; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
Publikováno v:
JMIR AI [JMIR AI] 2024 Jan 15; Vol. 3, pp. e51240. Date of Electronic Publication: 2024 Jan 15.